5AM VENTURE MANAGEMENT, LLC Holdings

5AM VENTURE MANAGEMENT, LLC is an investment fund managing more than 521.97M US dollars. The largest holdings include CinCor Pharma, Entrada Therapeutics and Rallybio. In Q3 2022 the fund bought assets of total value of 91.14M US dollars and sold assets of total value of 2.44M US dollars.

$521.96M

portfolio value

+30.13%

quarter

-44.88%

1 year

5AM VENTURE MANAGEMENT, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q2 2020	107755000	16860000
Q4 2020	3713000	74972000
Q1 2021	288444000	12568000
Q2 2021	36664000	5408000
Q3 2021	101555000	592000
Q4 2021	190988000	63901000
Q1 2022	87954000	12195000
Q2 2022	22991000	4215000
Q3 2022	91138000	2436000

5AM VENTURE MANAGEMENT, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology CinCor Pharma, Inc. Portfolio share: 31.05% Portfolio value: 162.05M Avg. open price: $18.84 Current price: $12.33 P/L: -34.55% Bought +13.83% shares Q3 2022	share	31.05%	162.05M	$18.84	$12.33	-34.55%	Bought +13.83% shares Q3 2022
Biotechnology Entrada Therapeutics, Inc. Portfolio share: 13.31% Portfolio value: 69.47M Avg. open price: N/A Current price: $17.96 P/L: N/A N/A Q4 2021	share	13.31%	69.47M	N/A	$17.96	N/A	N/A Q4 2021
Biotechnology Rallybio Corporation Portfolio share: 10.34% Portfolio value: 53.98M Avg. open price: N/A Current price: $5.35 P/L: N/A Sold -6.28% shares Q2 2022	share	10.34%	53.98M	N/A	$5.35	N/A	Sold -6.28% shares Q2 2022
Health Information Services Pear Therapeutics, Inc. Portfolio share: 6.61% Portfolio value: 34.48M Avg. open price: N/A Current price: $1.96 P/L: N/A Sold -9.28% shares Q3 2022	share	6.61%	34.48M	N/A	$1.96	N/A	Sold -9.28% shares Q3 2022
Biotechnology Akouos, Inc. Portfolio share: 5.36% Portfolio value: 27.95M Avg. open price: N/A Current price: $13.29 P/L: N/A Sold -10.20% shares Q4 2020	share	5.36%	27.95M	N/A	$13.29	N/A	Sold -10.20% shares Q4 2020
Biotechnology Vor Biopharma Inc. Portfolio share: 4.85% Portfolio value: 25.32M Avg. open price: N/A Current price: $4.72 P/L: N/A Sold -4.94% shares Q4 2021	share	4.85%	25.32M	N/A	$4.72	N/A	Sold -4.94% shares Q4 2021
Biotechnology scPharmaceuticals Inc. Portfolio share: 4.17% Portfolio value: 21.74M Avg. open price: $7.4 Current price: $6.9 P/L: -6.76% Sold -6.36% shares Q3 2022	share	4.17%	21.74M	$7.4	$6.9	-6.76%	Sold -6.36% shares Q3 2022
Biotechnology IDEAYA Biosciences, Inc. Portfolio share: 3.42% Portfolio value: 17.84M Avg. open price: N/A Current price: $17.77 P/L: N/A Sold -14.43% shares Q3 2022	share	3.42%	17.84M	N/A	$17.77	N/A	Sold -14.43% shares Q3 2022
Biotechnology Arvinas, Inc. Portfolio share: 3.41% Portfolio value: 17.79M Avg. open price: N/A Current price: $39.53 P/L: N/A Sold -20.00% shares Q2 2021	share	3.41%	17.79M	N/A	$39.53	N/A	Sold -20.00% shares Q2 2021
Biotechnology Crinetics Pharmaceuticals, Inc. Portfolio share: 3.24% Portfolio value: 16.93M Avg. open price: N/A Current price: $18.32 P/L: N/A Sold -36.70% shares Q4 2021	share	3.24%	16.93M	N/A	$18.32	N/A	Sold -36.70% shares Q4 2021
Biotechnology Impel Pharmaceuticals Inc. Portfolio share: 2.69% Portfolio value: 14.04M Avg. open price: N/A Current price: $2.9 P/L: N/A N/A Q2 2021	share	2.69%	14.04M	N/A	$2.9	N/A	N/A Q2 2021
Biotechnology Cogent Biosciences, Inc. Portfolio share: 2.26% Portfolio value: 11.79M Avg. open price: $7.49 Current price: $12.5 P/L: +66.89% Sold -30.00% shares Q3 2022	share	2.26%	11.79M	$7.49	$12.5	+66.89%	Sold -30.00% shares Q3 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 1.91% Portfolio value: 9.94M Avg. open price: N/A Current price: $26.84 P/L: N/A N/A Q3 2022	share	1.91%	9.94M	N/A	$26.84	N/A	N/A Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 1.75% Portfolio value: 9.12M Avg. open price: $16.44 Current price: $21.89 P/L: +33.15% Sold -50.50% shares Q3 2022	share	1.75%	9.12M	$16.44	$21.89	+33.15%	Sold -50.50% shares Q3 2022
Biotechnology Homology Medicines, Inc. Portfolio share: 1.40% Portfolio value: 7.30M Avg. open price: N/A Current price: $1.47 P/L: N/A Sold -18.06% shares Q4 2020	share	1.40%	7.30M	N/A	$1.47	N/A	Sold -18.06% shares Q4 2020
Biotechnology Avidity Biosciences, Inc. Portfolio share: 1.22% Portfolio value: 6.37M Avg. open price: N/A Current price: $11.18 P/L: N/A Sold -29.70% shares Q4 2021	share	1.22%	6.37M	N/A	$11.18	N/A	Sold -29.70% shares Q4 2021
Biotechnology Janux Therapeutics, Inc. Portfolio share: 1.16% Portfolio value: 6.04M Avg. open price: N/A Current price: $13.5 P/L: N/A N/A Q2 2021	share	1.16%	6.04M	N/A	$13.5	N/A	N/A Q2 2021
Biotechnology Pharvaris N.V. Portfolio share: 0.86% Portfolio value: 4.50M Avg. open price: N/A Current price: $2.02 P/L: N/A N/A Q2 2022	share	0.86%	4.50M	N/A	$2.02	N/A	N/A Q2 2022
Shell Companies 5:01 Acquisition Corp. Portfolio share: 0.70% Portfolio value: 3.65M Avg. open price: N/A Current price: $10 P/L: N/A N/A Q4 2020	share	0.70%	3.65M	N/A	$10	N/A	N/A Q4 2020
Biotechnology Gemini Therapeutics, Inc. Portfolio share: 0.16% Portfolio value: 860K Avg. open price: N/A Current price: $1.7 P/L: N/A N/A Q3 2022	share	0.16%	860K	N/A	$1.7	N/A	N/A Q3 2022
Biotechnology Cidara Therapeutics, Inc. Portfolio share: 0.14% Portfolio value: 712K Avg. open price: N/A Current price: $0.6 P/L: N/A Sold -43.46% shares Q3 2021	share	0.14%	712K	N/A	$0.6	N/A	Sold -43.46% shares Q3 2021
Biotechnology Cabaletta Bio, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $4.97 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$4.97	N/A	Sold -100.00% shares Q3 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $37.72 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$37.72	N/A	Sold -100.00% shares Q3 2022

Showing TOP 23 5AM VENTURE MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of 5AM VENTURE MANAGEMENT, LLC?

The biggest position of the 5AM VENTURE MANAGEMENT, LLC is CinCor Pharma, Inc. (CINC) with 31.05% portfolio share worth of 162.05M US dollars.

Top 5 5AM VENTURE MANAGEMENT's holdings represent 66.66% of the portfolio:

CinCor Pharma, Inc. (CINC) – 31.05%
Entrada Therapeutics, Inc. (TRDA) – 13.31%
Rallybio Corporation (RLYB) – 10.34%
Pear Therapeutics, Inc. (PEAR) – 6.61%
Akouos, Inc. (AKUS) – 5.36%

Who is the portfolio manager of 5AM VENTURE MANAGEMENT, LLC?

The portfolio manager of the 5AM VENTURE MANAGEMENT, LLC is .

What is the total asset value of the 5AM VENTURE MANAGEMENT, LLC portfolio?

5AM VENTURE MANAGEMENT, LLC total asset value (portfolio value) is 521.97M US dollars.

Who is ?

is the portfolio manager of the 5AM VENTURE MANAGEMENT, LLC.

What is (5AM VENTURE MANAGEMENT, LLC) fund performance?

5AM VENTURE MANAGEMENT's quarterly performance is +30.13%, annualy -44.88%.

What is the 5AM VENTURE MANAGEMENT, LLC CIK?

5AM VENTURE MANAGEMENT's Central Index Key is 0001799883 .